← Back to Search

Other

Arm A for Osteoarthritis

Phase 2
Waitlist Available
Research Sponsored by Sun Pharmaceutical Industries Limited
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 26
Awards & highlights

Study Summary

This study is evaluating whether a drug called MM-II may help treat knee osteoarthritis.

Eligible Conditions
  • Osteoarthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 26
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 26 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from Baseline in Western Ontario and McMaster Universities osteoarthritis index (WOMAC) A pain score
Secondary outcome measures
Weekly average of daily global pain scores by VAS
Weekly average of daily knee pain scores by VAS

Trial Design

6Treatment groups
Experimental Treatment
Placebo Group
Group I: Arm CExperimental Treatment1 Intervention
MM-II 6 ml
Group II: Arm BExperimental Treatment1 Intervention
MM-II 3 ml
Group III: Arm AExperimental Treatment1 Intervention
MM-II 1 ml
Group IV: Arm 4Placebo Group1 Intervention
Placebo 1ml
Group V: Arm 5Placebo Group1 Intervention
Placebo 3ml
Group VI: Arm 6Placebo Group1 Intervention
Placebo 6ml
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MM-II dose III
2020
Completed Phase 2
~400
MM-II dose II
2020
Completed Phase 2
~400
MM-II dose I
2020
Completed Phase 2
~400

Find a Location

Who is running the clinical trial?

Sun Pharmaceutical Industries LimitedLead Sponsor
64 Previous Clinical Trials
13,114 Total Patients Enrolled
Moebius Medical Ltd.Industry Sponsor
1 Previous Clinical Trials
40 Total Patients Enrolled
1 Trials studying Osteoarthritis
40 Patients Enrolled for Osteoarthritis
Nordic Bioscience Clinical Development (NBCD)UNKNOWN
2 Previous Clinical Trials
678 Total Patients Enrolled
2 Trials studying Osteoarthritis
678 Patients Enrolled for Osteoarthritis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Florida
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Efficacy and Safety of MM-II for Treatment of Knee Pain in Subjects With Symptomatic Knee Osteoarthritis
2020. "Efficacy and Safety of MM-II for Treatment of Knee Pain in Subjects With Symptomatic Knee Osteoarthritis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04506463.
~92 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top